聚乙二醇缩水甘油醚对丝素蛋白膜的改性

合成了不同分子量的聚乙二醇缩水甘油醚（PEGO），用1H－NMR，红外吸收光谱对其进行了表征，并将其用于改性丝素膜，用X射线衍射法，氨基酸分析仪研究了PEGO改性丝素膜的结构，并对改性丝素膜中的溶出率以及力学性能进行了测试，结果表明，PEGO可以改变丝素膜的结构，降低丝素大分子的溶出率，改性后的丝素膜具有较好的拉伸强度和较大的断裂伸长率，得到了较为柔韧的改性丝素膜。     

Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000

The aim of the present study was to enhance the dissolution rate of valdecoxib using its solid dispersions (SDs) with polyethylene glycol (PEG) 4000. The phase solubility behavior of valdecoxib in the presence of various concentrations of PEG 4000 in water was obtained at 37°C. The solubility of valdecoxib increased with increasing amount of PEG 4000 in water. Gibbs free energy (ΔG°_tr) values were all negative, indicating the spontaneous nature of valdecoxib solubilization, and they decreased with increase in the PEG 4000 concentration, demonstrating that the reaction conditions became more favorable as the concentration of PEG 4000 increased. The SDs of valdecoxib with PEG 4000 were prepared at 1:1, 1:2, 1:5, and 1:10 (valdecoxib: PEG 4000) ratio by melting method. Evaluation of the properties of the SDs was performed by using dissolution, Fourier-transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC), X-ray diffraction (XRD), and scanning electron microscopy (SEM) studies. The SDs of valdecoxib with PEG 4000 exhibited enhanced dissolution rate of valdecoxib, and the rate increased with increasing concentration of PEG 4000 in SDs. Mean dissolution time (MDT) of valdecoxib decreased significantly after preparation of SDs and physical mixture with PEG 4000. The FTIR spectroscopic studies showed the stability of valdecoxib and absence of well-defined valdecoxib-PEG 4000 interaction. The DSC and XRD studies indicated the amorphous state of valdecoxib in SDs of valdecoxib with PEG 4000. The SEM pictures showed the formation of effective SDs of valdecoxib with PEG 4000, since well-defined changes in the surface nature of valdecoxib, SDs, and physical mixture were observed.     

PEG/壳聚糖相变材料储热性能研究

用物理共混法将PEG和壳聚糖共混物改性,得到具有固-固相变性能的储能材料,用DSC具体研究了PEG的质量分数及PEG的相对分子质量对共混材料的相变温度和相变焓的影响。结果表明,不同相对分子质量的PEG在63～68℃之间具有较大的相变焓,且相变焓在180～220J/g之间,均可做为相变储能材料;相对分子质量为8000的PEG相对于其他的PEG更适宜做相变储能材料,共混物中PEG的质量分数低于85%时才表现为固-固相变材料。     

不规则LDPC码构造方法研究及其改进

通过对码的度数分布进行设计,非规则LDCP码能获得比规则LDPC码更好的性能,但非规则LDPC码在高SNR区会出现错误平层.在本文中,利用ACE算法,对非规则LDPC码的构造方法PEG算法进行改进,以降低非规则LDPC码的错误平层.最后Matlab模拟证明此算法有效提高了非规则LDPC码在加性高斯白噪声通道中的纠错性能.     

Miscibility of polymethylmethacrylate and polyethyleneglycol blends in tetrahydrofuran

The miscibility of polymethylmethacrylate (PMMA) and polyethyleneglycol (PEG) blends in tetrahydrofuran (THF) has been investigated by viscosity, density, refractive index, and ultrasonic velocity studies. Various interaction parameters such as polymer–solvent and blend–solvent interaction parameters and heat of mixing have been calculated using the viscosity, density, and ultrasonic velocity data. The results indicated the existence of positive interactions in the blend polymer solutions and that they are miscible in THF in the entire composition range. The study also revealed that variation in the temperature does not affect the miscibility of PMMA and PEG blends in THF significantly. The presence of hydrogen bonding in the blends in the solid state has also been indicated by FTIR studies. © 2008 Wiley Periodicals, Inc. J Appl Polym Sci, 2009     

Encapsulation of diclofenac sodium with acidic copolymer hydrogels based on PEG/poly(N‐isopropylacrylamide‐co‐2‐acrylamido‐2‐methyl‐1‐propanesulfonic acid) semi‐interpenetrating network using in situ loading technique

A pH‐ and temperature‐responsive semi‐interpenetrating copolymer PEG6000/poly(NIPA‐co‐AMPS) (PEG/AMPS‐co‐NIPA SIPN), for short PEG SIPN, was made by ammonium persulfate‐initiated suspension copolymerization of N‐isopropylacrylamide, 2‐acrylamido‐2‐methylpropanesulphonic acid, and N,N′‐methylene‐bis‐acrylamide (MBAA; crosslinker) in the presence of PEG6000. The PEG SIPN copolymer matrices containing nanostructures made in the high‐temperature copolymerization resulted in channels for PEG and facile migration of drugs. In drug encapsulation or drug‐loading process, one can easily ignore or pay less attention to the interaction between a drug and its encapsulation materials; however, the ignored interactions may induce problems in drug properties or the release behavior in use. Sodium diclofenac (DFNa) precipitates as the carboxylic acid form in an acidic environment, and it is challenging to encapsulate sodium diclofenac in such an acidic matrix without precipitation of the sparingly soluble acid form of DFNa on the surface of the polymer substrate. To avoid bulky precipitation in drug loading, an in situ loading technique was developed for producing gel spheres with DFNa uniformly distributed in the polymer matrix. The technique is based on fast polymerization of spherical droplets of a pregel solution in which the drug is dissolved. Diffusion‐loading prodrugs were made in comparison with in situ loading prodrugs in thermal, release kinetics, and release behavior. Drug release profiles (in pH 7.4 phosphate buffer) show that the new drug loading technique gives controlled release during a period of about 7 days at 37°C. By contrast, gel spheres loaded with sodium diclofenac using the conventional diffusion technique produced almost total release of the drug within about 24 h. The thermal stability of sodium diclofenac, the PEG/AMPS‐co‐NIPA SIPN, and the prodrugs made with the SIPN and sodium diclofenac was studied. A near zero‐order release kinetics was found in the in vitro release of sodium diclofenac with in situ loading PEG SIPN prodrug. We have, for the first time, studied sodium diclofenac release behavior from the PEG SIPN hydrogel systems. © 2009 Wiley Periodicals, Inc. J Appl Polym Sci, 2009     

Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent

Accurate diagnosis in early stage is vital for the treatment of Hepatocellular carcinoma. The aim of this study was to investigate the potential of poly lactic acid–polyethylene glycol/gadolinium–diethylenetriamine-pentaacetic acid (PLA–PEG/Gd–DTPA) nanocomplexes using as biocompatible molecular magnetic resonance imaging (MRI) contrast agent. The PLA–PEG/Gd–DTPA nanocomplexes were obtained using self-assembly nanotechnology by incubation of PLA–PEG nanoparticles and the commercial contrast agent, Gd–DTPA. The physicochemical properties of nanocomplexes were measured by atomic force microscopy and photon correlation spectroscopy. The T₁-weighted MR images of the nanocomplexes were obtained in a 3.0 T clinical MR imager. The stability study was carried out in human plasma and the distribution in vivo was investigated in rats. The mean size of the PLA–PEG/Gd–DTPA nanocomplexes was 187.9 ± 2.30 nm, and the polydispersity index was 0.108, and the zeta potential was −12.36 ± 3.58 mV. The results of MRI test confirmed that the PLA–PEG/Gd–DTPA nanocomplexes possessed the ability of MRI, and the direct correlation between the MRI imaging intensities and the nano-complex concentrations was observed (r = 0.987). The signal intensity was still stable within 2 h after incubation of the nanocomplexes in human plasma. The nanocomplexes gave much better image contrast effects and longer stagnation time than that of commercial contrast agent in rat liver. A dose of 0.04 mmol of gadolinium per kilogram of body weight was sufficient to increase the MRI imaging intensities in rat livers by five-fold compared with the commercial Gd–DTPA. PLA–PEG/Gd–DTPA nanocomplexes could be prepared easily with small particle sizes. The nanocomplexes had high plasma stability, better image contrast effect, and liver targeting property. These results indicated that the PLA–PEG/Gd–DTPA nanocomplexes might be potential as molecular targeted imaging contrast agent.     

集成干扰素突变体的构建、表达及纯化

目的构建高效且可供单甲氧基聚乙二醇马来酰亚胺(mPEG-MAL)定点修饰的集成干扰素突变体(IIFNm108),并进行表达、纯化及鉴定。方法采用同源序列对比、空间结构模拟并结合α干扰素与受体结合的特点设计突变位点。用重叠延伸PCR法,扩增IIFNm108基因,与pET-23b载体连接,构建重组表达质粒pET-23b-IIFNm108,转化E.coli BL21(DE3),IPTG诱导表达,所得包涵体经变性、复性、DEAE阴离子交换及凝胶过滤两步层析纯化后,进行各项鉴定。结果重组表达质粒经双酶切及测序鉴定证明构建正确。目的蛋白的表达量占菌体总蛋白的30%以上,主要以包涵体形式存在。纯化的IIFNm108蛋白纯度大于95%,比活性约为(2.08±0.17)×108IU/mg,N-端、C-端氨基酸序列与理论一致,相对分子质量为19500,可与mPEG-MAL成功交联。结论已获得一种高效且可供mPEG-MAL定点修饰的集成干扰素突变体IIFNm108。     

PEG/增塑剂共混物相容性的分子动力学模拟和介观模拟

为解决含能钝感增塑剂应用于硝酸酯增塑聚醚(NEPE)推进剂的问题,研究了增塑剂三羟甲基乙烷三硝酸酯(TMETN)、硝化甘油(NG)、1,2,4-丁三醇三硝酸酯(BTTN)与粘合剂预聚物聚乙二醇(PEG)的相容性。采用分子动力学模拟计算了PEG、TMETN、NG、BTTN四种纯物质的溶度参数及分子内和分子间径向分布函数,得到相容性优劣顺序为:TMETN/PEGBTTN/PEGNG/PEG。BTTN分子中的亚甲基和TMETN的结构削弱了自身分子间作用、降低了与PEG溶度参数的差值;分析了共混物的结合能及分子间径向分布函数,认为增塑剂与PEG相容的本质为"分子间以非键作用相结合,范德华作用占主要比重"。此外,增塑剂与PEG分子的极性越相近、范德华作用的占比越大;通过介观模拟得到体系的介观形态演变过程,发现NG/PEG及BTTN/PEG易发生相分离、TMETN/PEG仅发生轻微的同相归并。最终得出:含能钝感增塑剂TMETN与PEG的相容性优于BTTN及NG,可以考虑将其代替或部分代替NG、降低NEPE推进剂的感度,为低易损战术武器的发展提供依据。